Information
-
Trademark
-
98589121
-
International Classifications
-
Filing Date
June 06, 2024
a year ago
-
Transaction Date
March 11, 2025
a year ago
-
Status Date
March 11, 2025
a year ago
-
Published for Opposition Date
January 14, 2025
a year ago
-
Location Date
March 11, 2025
a year ago
-
Status Code
688
-
Current Location
INTENT TO USE SECTION
Employee Name
LEASER, ANDREW
-
Attorney Docket Number
33324/60091
Attorney Name
Tiffany D. Gehrke
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
4
Mark Identification
CTX340
Case File Statements
- GS0051: Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of renal and cardiovascular diseases or conditions; pharmaceutical and biopharmaceutical agents for the treatment of renal and cardiovascular diseases or conditions in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of renal and cardiovascular diseases or conditions in the field of in vivo gene editing therapy
- GS0421: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy
Case File Event Statements
-
6/6/2024 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
12/20/2024 - a year ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/20/2024 - a year ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
12/19/2024 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/8/2025 - a year ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
1/14/2025 - a year ago
6 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/14/2025 - a year ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/11/2025 - a year ago
8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM